30211. Adulteration and misbranding of tablets of quinine, Iron, and zinc 
valerianates and migraine tablets. U. S. v. Hance Bros. & White, Inc. 
Plea of nolo contendere.     Judgment of guilty.    Fine, $25.     (F. & D.
No. 40784.    Sample Nos. 67302-C, 67304-C.)
The strength and purity of these drug preparations fell below the professed 
standard under which they were sold in that they contained smaller amounts 
of certain therapeutic agents than declared on the labels.
On April 27, 1938, the United States attorney for the Eastern District of 
Pennsylvania, acting upon a report by the Secretary of Agriculture, filed in 
the district court an information against Hance Bros. & White, Inc., Philadel- 
, phia, Pa., alleging shipment by said company in violation of the Food and Drugs 
Act on or about January 15, 1937, from the State of Pennsylvania into the - 
State of New Jersey of quantities of the above-named drug products which were 
adulterated and misbranded.
The tablets of quinine, iron, and zinc valerianates were alleged to be adul- 
terated in that their strength and purity fell below the professed standard and 
quality under which they were sold in that each tablet was represented to 
contain 1 grain (0.065 gram) of quinine valerianate, 1 grain of iron valerianate, 
and 1 grain of zinc valerianate; whereas each of said tablets contained less of 
said drugs than represented, namely, not more than 0.59 grain (0.038 gram) of 
quinine valerianate, not more than 0.49 grain (0.032 gram) of iron valerianate, 
and not more than 0.62 grain (0.040 gram) of zinc valerianate. Misbranding 
was alleged in that the statement "Tablets Quinine Iron and Zinc Valerianates 
* * * Quinine Valer., 1 Gr. (0.065 Gm.) Iron Valer., 1 Gr. (0.065 Gm.) Zinc 
Valer., 1 Gr. (0.065 Gm.)," borne on the bottle label, were false and misleading 
since the tablets contained smaller amounts of quinine, iron, and zinc valerianates 
than those represented.
The migraine tablets were alleged to be adulterated in that their strength 
and purity fell below the professed standard and quality under which they were 
sold in that each of the said tablets was represented to contain 2% grains of 
acetanilide, % grain of monobromated camphor, and 1 grain of sodium salicylate; 
whereas each of said tablets contained less of the said drugs than represented, 
namely, not more than 2.17 grains of acetanilide, not more than 0.40 grain of 
monobromated camphor, and not more than 0.87 grain of sodium salicylate. 
Misbranding was alleged in that the statements, "Tablets * * * Acetanilide 
2% grs.   Camphor Monob % gr.    Sodium Salicylate 1 gr.," borne on the bottle
label, were false and misleading since the tablets contained less acetanilide, less 
monobromated camphor, and less sodium salicylate than so represented.
On September 30, 1938, a plea of nolo contendere was entered on behalf of 
the defendants. On February 3, 1939, the court adjudged the defendant guilty 
and imposed a fine of $25.
HARRY L, BROWN, Acting Secretary of Agriculture.